ArticleFrontiers in microbiology2017
Antimicrobial Resistance and Molecular Epidemiology of ESBL-Producing
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review and meta-analysis on the prevalence of extended-spectrum beta-Lactamase-ProducingAfrican health sciences · 2024Pooled it
- Article
- High Prevalence and Genomic Characterization of Extended-SpectrumChina CDC weekly · 2025Article
- Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses.Clinical microbiology reviews · 2025Review
- Genomic Characterization and Antimicrobial Resistance of ESBL-Producing,Infection and drug resistance · 2025Article
- Public health concern of antimicrobial resistance and virulence determinants in E. coli isolates from oysters in Egypt.Scientific reports · 2024Article
- Current epidemiologic features and health dynamics of ESBL-producingBiosafety and health · 2024Review
- Emergence of ST1193 Clone in Maternal and Neonatal ESBL-ProducingInfection and drug resistance · 2023Article
- Antimicrobial Resistance Profile by Metagenomic and Metatranscriptomic Approach in Clinical Practice: Opportunity and Challenge.Antibiotics (Basel, Switzerland) · 2022Review
- Antimicrobial Resistance and Molecular Epidemiology ofFrontiers in medicine · 2021Article
- Antimicrobial Resistance in Agri-Food Chain and Companion Animals as a Re-emerging Menace in Post-COVID Epoch: Low-and Middle-Income Countries Perspective and Mitigation Strategies.Frontiers in veterinary science · 2020Review
- Article
- Assessment of the Exposure of Turkey Farmers to Antimicrobial Resistance Associated with Working Practices.Veterinary sciences · 2019Article
- CTX-M type extended-spectrum β-lactamase inThe Indian journal of medical research · 2019Article
- Metagenomics: aid to combat antimicrobial resistance in diarrhea.Gut pathogens · 2019Review
- Phenotypic and genotypic characterization of multi-drug-resistantInfection and drug resistance · 2019Article
- Human, animal and environmental contributors to antibiotic resistance in low-resource settings: integrating behavioural, epidemiological and One Health approaches.Proceedings. Biological sciences · 2018Review
- Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producingInfection and drug resistance · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate antimicrobial resistance and molecular epidemiology of extended-spectrum β-lactamase (ESBL)-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.